ClinicalTrials.gg
Sign In

Kidney Neoplasms clinical trials

The registry lists 969 studies for Kidney Neoplasms across more than 10 countries. 210 are recruiting or about to start. 279 of them are mainly about Kidney Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Carcinoma, Renal Cell: 2,691 studies, 556 open.

ClinicalTrials.gov finds 3,348 studies for Kidney Neoplasms. How that becomes 968 here

This page counts the studies the registry files under Kidney Neoplasms, and those it files under no condition that list Kidney Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 3,348Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,662Filed under a narrower condition, counted on its own pageCarcinoma, Renal Cell 1,482 · Wilms Tumor 143 · Clear-cell metastatic renal cell carcinoma 10
  3. −5List Kidney Neoplasms as a condition, but the registry did not file them under itMost often written as “Recurrent Childhood Kidney Neoplasm” (1), “Childhood Kidney Neoplasm” (1), and “Clear Cell Renal Cancer” (1). The registry filed them under other conditions only, most often Hepatoblastoma (1) and Precursor Cell Lymphoblastic Leukemia-Lymphoma (1).
  4. −713Match it another way11 name it in the title, 5 in a keyword, and 697 by a synonym or other text the search reads.
  5. 968The count on this page11 of them list Kidney Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Kidney Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
471
Recruiting
173
Terminated
113
Status unknown
81
Active, not recruiting
58
Withdrawn
33

Phase

Phase 2
345
Phase 1
229
Phase 3
57
Phase 4
21
Early Phase 1
9

Where

United States
551
France
108
China
68
United Kingdom
66
Canada
62
Italy
57

Who runs them

National Cancer Institute (NCI) (55) · Memorial Sloan Kettering Cancer Center (35) · Pfizer (21) · M.D. Anderson Cancer Center (21) · Children's Oncology Group (15) · Bristol-Myers Squibb (12) · National Institutes of Health Clinical Center (CC) (11) · Novartis Pharmaceuticals (10)

What is being tested here

Drugs under test in Kidney Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pembrolizumab439
Nivolumab3317
Axitinib3412
Ipilimumab3311
Cabozantinib316
Fludarabine2010
Casdatifan213
Lenvatinib213
Lutetium (¹⁷⁷Lu) vipivotide tetraxetan213
Gallium-68202

Drug classes tested here Immune checkpoint inhibitors 13 open · Tyrosine kinase inhibitors (TKIs) 10 open · Antimetabolites 2 open · Alkylating agents 2 open · Angiogenesis inhibitors 1 open

Coming up

14phase 3 studies under way
82studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 173 Kidney Neoplasms studies recruiting now, 133 (77%) set no upper age limit and 15 (9%) stop at 75 or younger. 20 (12%) take children under 18. 1 (1%) are for women only and 2 (1%) for men only; 24 (14%) take healthy volunteers.

Recruiting studies that take each age, of 173
AgeWomenMen
1018 (10%)18 (10%)
18162 (94%)163 (94%)
30165 (95%)166 (96%)
40166 (96%)167 (97%)
50167 (97%)168 (97%)
65169 (98%)170 (98%)
75165 (95%)166 (96%)
85143 (83%)144 (83%)

Across all 969 studies, recruiting or not: 11% stop at 75 or younger and 5% at 65; 14% take children; <1% are for women only and 1% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Kidney Neoplasms studies take

Of 74 phase 2 interventional studies under Kidney Neoplasms, half reached primary completion within 67 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 156 mo33–75 · 65 studies53 mo28–61 · 42 studies—
Phase 1/266 mo61–91 · 31 studies——
Phase 267 mo36–112 · 74 studies—67 mo41–112 · 64 studies
Phase 370 mo35–89 · 22 studies——
Interventional, no phase42 mo21–90 · 97 studies—48 mo24–94 · 90 studies
Observational74 mo28–… · 107 studies—74 mo34–… · 89 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Results posted2

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 969. Browse all 969 → or search them.